ZZ, V. B. Brooks, ed., pp. 1017-1061, The American Physiological
Society, Washington, DC.
DiChiara, G., M. Morelli, A. Imperato, and M. L. Porceddu (1982) A
re-evaluation of the role of superior colliculus in turning behavior.
Brain Res. 237: 61-77.
Graybiel, A. M., and C. W. Ragsdale (1979) Fiber connections of the
basal ganglia. Prog. Brain Res. 51: 239-283.
Herrera-Marschitz, M., and U. Ungerstedt (1984a) Evidence that striatal efferents relate to different dopamine receptors. Brain Res. 323:
269-278.
Herrera-Marschitz, M., and U. Ungerstedt (1984b) Evidence that apomorphine and pergolide induce rotation in rats by different actions
on Dl and D2 receptor sites. Eur. J. Pharmacol. 98: 165-176.
Homykiewicz, 0. (1982) Brain neurotransmitter changes in Parkinson's disease. In Movement Disorders, C. D. Marsden and S. Fahn,
eds., pp. 41-58, Butterworth, London.
Jones, E. G., and R. Y. Leavitt (1974) Retrograde axonal transport
and the demonstration ofnonspecific projections to the cerebral cortex
and striatum from thalamic intralaminar nuclei in the rat, cat, and
monkey. J. Comp. Neurol. 154: 349-378.
Kebabian. J. W.. and D. B. Calne (1979) Multiole receotors for do- pamine: Nature 277: 93-96. ' ' A A
Kozlowski, M. R., and J. F. Marshall (1980) Plasticity of [`%]2-deoxy- d-glucose incorporation into neostriatum and related structures in
response to dopamine neuron damage and apomorphine replacement.
Brain Res. 197: 167-183.
Markstein, R. (198 1) Neurochemical effectsof some ergot derivatives:
A basis for their antiparkinson actions. J. Neural Transmission 51:
39-59.
Matthews, R. T., and D. C. German (1986) Evidence for a functional
role of dopamine type- 1 (DI) receptors in the substantia nigra of rats.
Eur. J. Pharmacol. 120: 87-93.
Mitchell, I. J., and A. R. Crossman (1984) In defense ofoptical density
ratios in 2-deoxyglucose autoradiography. Brain Res. 298: 19 l-l 92.
Molloy, A. G., and J. L. Waddington (1984) Dopaminergic behavior
stereospecifically promoted by the D, agonist R-SK&F 38393 and
selectively blocked by the D, antagonist SCH 23390. Psychopharmacology 82: 409-4 10.
Onali, P., M. C. Olianas, and G. L. Gessa (1985) Characterization of
dopamine receptors mediating inhibition of adenylate cyclase activity
in rat striatum. Mol. Pharmacol. 28: 138-145.
Palacios, J. M., and K. H. Wiederhold (1985) Dopamine D2 receptor
agents, but not dopamine D 1, modify brain glucose metabolism. Brain
Res. 327: 390-394.
Palacios, J. M., and K. H. Wiederhold (1986) Pharmacological characterization of dopaminergic effect in brain glucose metabolism: The
“2-deoxyglucose dopaminergic fingerprints.” Sot. Neurosci. Abstr.
12: 1409.
Paxinos, G., and C. Watson (1982) The Rat Brain in Stereotaxic
Coordinates, Academic, New York.
Porceddu, M. L., 0. Giorgi, E. Ongini, S. Mele, and G. Biggio (1986)
)H-SCH 23390 binding sites in the rat substantia nigra: Evidence for
a mesvnautic localization and innervation bv donamine. Life Sci. 39:
321-328.'
Rosengarten, H., J. W. Schweitzer, and A. J. Friedhoff (1983) Induction of oral dyskinesias in naive rats by Dl stimulation. Life Sci. 33:
2479-2482.
Savasta, M., A. Dubois, and B. Scatton (1986) Autoradiographic lo- calization of D, dopamine receptors in the rat brain with [)H]SCH
23390. Brain Res. 375: 291-301.
Schachter, M., P. Btdard, A. G. Debono, P. Jenner, C. D. Marsden, P.
Price, J. D. Parkes, J. Keenan, B. Smith, J. Rosenthaler, R. Horowski,
and R. Dorow (1980) The role of D, and D, receptors. Nature 286:
157-159.
Seeman, P. (1980) Brain dopamine receptors. Pharmacol. Rev. 32:
229-3 13.
Setler, P. E., H. M. Saran, C. L. Zirkle, and H. L. Saunders (1978) The
central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50:
419-430.
Sharp, F. R., T. S. Kilduff, S. Bzorchami, H. C. Heller, and A. F. Ryan
(1983) The relationship of local cerebral glucose utilization to optical
density ratios. Brain Res. 263: 97-103.
Sibley, D. R., S. D. Leff, and I. Creese (1982) Interactions of novel
dopaminergic ligands with D, and D, dopamine receptors. Life Sci.
31: 637-645.
